Mary Hitt, MD
Hospitalist · Jackson, MSNPI 1073132775
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $953, more than ten times the $37 reported in 2021.
Across 78 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$232
- Merck$172
- Bristol Myers Squibb$157
- Incyte Corporation$111
- Pfizer$99
- Takeda Pharmaceuticals U.S.A., Inc.$97
- plus $687 from 19 others
What the payments were for
- Food & beverage$1,555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 13 | $232 |
| Merck | 8 | $172 |
| Bristol Myers Squibb | 7 | $157 |
| Incyte Corporation | 5 | $111 |
| Pfizer | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| AstraZeneca | 4 | $69 |
| Novartis | 4 | $60 |
| Stemline Therapeutics Inc. | 2 | $48 |
| Boehringer Ingelheim | 3 | $47 |
| ADC Therapeutics America, Inc. | 2 | $41 |
| Agios Pharmaceuticals, Inc. | 2 | $40 |
| AbbVie | 2 | $39 |
| Beone Medicines USA, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 2 | $32 |
| Legend Biotech USA Inc. | 1 | $31 |
| Medtronic | 1 | $28 |
| Karyopharm Therapeutics Inc. | 1 | $28 |
| Sanofi | 1 | $25 |
| Inari Medical, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| AVEO Pharmaceuticals, Inc. | 1 | $17 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Emmaus Medical, Inc. | 1 | $16 |
How this compares
$1,555 in reported general payments places this provider in the 80th percentile of 102 hospitalist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $262 |
| Carvedilol | 28 | $156 |
| Amlodipine Besylate | 15 | $129 |
| Pantoprazole Sodium | 32 | $115 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $113 |
| Atorvastatin Calcium | 11 | $112 |
| Metoprolol Succinate | 11 | $96 |
| Ondansetron OdtOndansetron | 14 | $80 |
| Spironolactone | 20 | $70 |
| Furosemide | 13 | $49 |
| Hydrochlorothiazide | 15 | $30 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Jackson
- Kenneth BallJackson$3K
- Frederick AsherJackson$3K
- Bharat MalhotraJackson$3K
- Joshua JeterJackson$2K
- Rahat NoorJackson$2K
- Pradeep BathinaJackson$1K
- Seema McKenzieJackson$1K
- Navkiran JagdevJackson$1K
- David RiemJackson$1K
- Yousaf ZafarJackson$970
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.